TrademarkOpen
Search / United States / 90188939

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Service Mark

SYNAPTICURE

Registered
Used for: Referrals in the field of neurodegenerative medicine, namely, doctor and clinical trial referral services to patients…
Show more

Class 35: Referrals in the field of neurodegenerative medicine, namely, doctor and clinical trial referral services to patients with neurodegenerative diseases
Class 42: Providing medical research information in the nature of sharing data sets containing patient data for neurodegenerative-disease research purposes
Class 44: Providing telehealth in the nature of telemedicine services and health-care-consulting in the field of neurodegenerative disease; maintaining patient medical records electronically; genetic testing for medical purposes, namely, providing disease and genetic analysis services to patients by screening therapies best suited for individual patients through use of proprietary models

Class 35 – Advertising & retailClass 42 – Technology & SaaSClass 44 – Medical & beauty services

Status timeline

  1. 21 Sep 2020
    Application filed
    New Application Entered
  2. 1 Feb 2021
    Assigned to an examining attorney
    Assigned To Examiner
  3. 5 Feb 2021
    Office action issued
    Non-Final Action Written
  4. 2 Jun 2021
    Response to office action filed
    Teas Response To Office Action Received
  5. 9 Jun 2021
    Approved for publication
    Approved For Pub - Principal Register
  6. 13 Jul 2021
    Published for opposition
    Published For Opposition
  7. 7 Sep 2021
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 8 Feb 2022
    Statement of use filed
    Teas Statement Of Use Received
  9. 9 Mar 2022
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  10. 10 Mar 2022
    Statement of use accepted
    Notice Of Acceptance Of Statement Of Use E-Mailed
  11. 12 Apr 2022
    Registered on the Principal Register
    Registered-Principal Register
All 21 events
2022-04-12Registered-Principal Register
2022-03-10Notice Of Acceptance Of Statement Of Use E-Mailed
2022-03-09Allowed Principal Register - Sou Accepted
2022-03-03Statement Of Use Processing Complete
2022-03-02Case Assigned To Intent To Use Paralegal
2022-02-08Teas Statement Of Use Received
2022-02-08Use Amendment Filed
2021-09-07Noa Mailed - Sou Required From Applicant
2021-07-13Published For Opposition
2021-07-13Official Gazette Publication Confirmation E-Mailed
2021-06-23Notification Of Notice Of Publication E-Mailed
2021-06-09Approved For Pub - Principal Register
2021-06-03Teas/Email Correspondence Entered
2021-06-02Teas Response To Office Action Received
2021-06-02Correspondence Received In Law Office
2021-02-05Non-Final Action Written
2021-02-05Non-Final Action E-Mailed
2021-02-05Notification Of Non-Final Action E-Mailed
2021-02-01Assigned To Examiner
2020-10-26New Application Office Supplied Data Entered
2020-09-21New Application Entered

Goods & services by class

Class 35 Advertising & retail

Referrals in the field of neurodegenerative medicine, namely, doctor and clinical trial referral services to patients with neurodegenerative diseases

First use anywhere 1 Feb 2022 · First use in commerce 1 Feb 2022

Class 42 Technology & SaaS

Providing medical research information in the nature of sharing data sets containing patient data for neurodegenerative-disease research purposes

First use anywhere 1 Feb 2022 · First use in commerce 1 Feb 2022

Class 44 Medical & beauty services

Providing telehealth in the nature of telemedicine services and health-care-consulting in the field of neurodegenerative disease; maintaining patient medical records electronically; genetic testing for medical purposes, namely, providing disease and genetic analysis services to patients by screening therapies best suited for individual patients through use of proprietary models

First use anywhere 1 Feb 2022 · First use in commerce 1 Feb 2022

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 12 Apr 2022; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.